MeSH term
Frequency | Condition_Probility | Female | 5 | 0.0 |
Humans | 29 | 0.0 |
Acylation | 2 | 2.0 |
Animals | 15 | 0.0 |
Cell Line | 10 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
*Drosophila Proteins | 9 | 0.0 |
Male | 2 | 0.0 |
Mice | 12 | 0.0 |
Mice, Inbred C57BL | 6 | 0.0 |
Mice, Knockout | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Lipopolysaccharides/metabolism | 2 | 1.0 |
CHO Cells | 2 | 0.0 |
Cells, Cultured | 10 | 0.0 |
Hamsters | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Transfection | 7 | 0.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 3 | 0.0 |
Cytokines/biosynthesis | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Membrane Glycoproteins/*genetics | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Receptors, Cell Surface/*genetics | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Immunity, Cellular | 2 | 0.0 |
Membrane Glycoproteins/genetics/*metabolism | 3 | 1.0 |
Receptors, Cell Surface/genetics/*metabolism | 3 | 2.0 |
Solubility | 2 | 0.0 |
NF-kappa B/metabolism | 7 | 0.0 |
Receptors, Cell Surface/genetics/*immunology | 2 | 8.0 |
Lipoproteins/*pharmacology | 2 | 4.0 |
Membrane Glycoproteins/physiology | 2 | 1.0 |
Mycoplasma fermentans/*pathogenicity | 2 | 100.0 |
Receptors, Cell Surface/physiology | 2 | 1.0 |
Cell Line, Tumor | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Monocytes/*metabolism | 2 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Ligands | 2 | 0.0 |
Macrophages/metabolism | 3 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Signal Transduction | 4 | 0.0 |
Immunity, Natural | 2 | 0.0 |
Membrane Glycoproteins/*physiology | 3 | 1.0 |
Receptors, Cell Surface/*physiology | 3 | 1.0 |
